{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T13:40:06Z","timestamp":1755956406697,"version":"3.44.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T00:00:00Z","timestamp":1751587200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue Neurologique"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.neurol.2025.06.005","type":"journal-article","created":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T00:08:10Z","timestamp":1752624490000},"page":"644-651","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Criteria for the use of plasmapheresesis in optic neuritis: A practice review from French expert centers"],"prefix":"10.1016","volume":"181","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-2795-1484","authenticated-orcid":false,"given":"A.","family":"Gaulier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Touitou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.-B.","family":"Rougier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.P.","family":"Robert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5515-8249","authenticated-orcid":false,"given":"H.","family":"Merle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4383-7930","authenticated-orcid":false,"given":"M.","family":"Aubart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Cabre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Cochard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Stolowy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"De Seze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5170-5818","authenticated-orcid":false,"given":"A.","family":"Gueguen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5022-4681","authenticated-orcid":false,"given":"J.","family":"Aboab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Zephir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3162-5084","authenticated-orcid":false,"given":"A.","family":"Ungureanu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Caignard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Scherer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Gobert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7764-6016","authenticated-orcid":false,"given":"S.","family":"Saheb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Fage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1306-1908","authenticated-orcid":false,"given":"J.-B.","family":"Ducloyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Rivet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4718-0902","authenticated-orcid":false,"given":"S.","family":"Beltran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.-M.","family":"Guennoc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Audoin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.-A.","family":"Laville","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4183-9502","authenticated-orcid":false,"given":"P.","family":"Branger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.K.","family":"Khanna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Roth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4740-032X","authenticated-orcid":false,"given":"C.","family":"Bensa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Bursztyn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0569-629X","authenticated-orcid":false,"given":"D.","family":"Biotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Laplaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Brochet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Wiertlewski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1452-1398","authenticated-orcid":false,"given":"C.","family":"Froment","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-3355-7715","authenticated-orcid":false,"given":"P.","family":"Lebranchu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.neurol.2025.06.005_bib0200","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1056\/NEJM199202273260901","article-title":"A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group","volume":"326","author":"Beck","year":"1992","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.neurol.2025.06.005_bib0205","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.ophtha.2006.06.060","article-title":"Natural history of the visual impairment of relapsing neuromyelitis optica","volume":"114","author":"Merle","year":"2007","journal-title":"Ophthalmology"},{"issue":"9485","key":"10.1016\/j.neurol.2025.06.005_bib0210","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0140-6736(05)67102-4","article-title":"Relation between humoral pathological changes in multiple sclerosis and response to therapeutic plasma exchange","volume":"366","author":"Keegan","year":"2005","journal-title":"Lancet Lond Engl"},{"issue":"4","key":"10.1016\/j.neurol.2025.06.005_bib0215","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1001\/jamaneurol.2017.4842","article-title":"Differences in the responses to apheresis therapy of patients with 3 histopathologically classified immunopathological patterns of multiple sclerosis","volume":"75","author":"Stork","year":"2018","journal-title":"JAMA Neurol"},{"issue":"5","key":"10.1016\/j.neurol.2025.06.005_bib0220","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1212\/01.WNL.0000152873.82631.B3","article-title":"A double-blind, randomized trial of IV immunoglobulin treatment in acute optic neuritis","volume":"64","author":"Roed","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2025.06.005_bib0225","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1111\/j.1468-1331.2008.02258.x","article-title":"Treatment of refractory corticosteroid optic neuritis in multiple sclerosis patients with intravenous immunoglobulin","volume":"15","author":"Tselis","year":"2008","journal-title":"Eur J Neurol"},{"issue":"1","key":"10.1016\/j.neurol.2025.06.005_bib0230","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/s10384-020-00790-9","article-title":"Intravenous immunoglobulin treatment for steroid-resistant optic neuritis: a multicenter, double-blind, randomized, controlled phase III study","volume":"65","author":"Mimura","year":"2021","journal-title":"Jpn J Ophthalmol"},{"issue":"9","key":"10.1016\/j.neurol.2025.06.005_bib0235","first-page":"685","article-title":"[Clinical characteristics, treatment and prognosis of myelin oligodendrocyte glycoprotein antibody-associated optic neuritis in children]","volume":"100","author":"Hou","year":"2020","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"10.1016\/j.neurol.2025.06.005_bib0240","doi-asserted-by":"crossref","first-page":"102325","DOI":"10.1016\/j.msard.2020.102325","article-title":"Intravenous immunoglobulin for acute attacks in neuromyelitis optica spectrum disorders (NMOSD)","volume":"44","author":"Li","year":"2020","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.neurol.2025.06.005_bib0245","article-title":"Efficacy and safety of plasma exchange or immunoadsorption for the treatment of option neuritis in demyelinating diseases: a systematic review and meta-analysis","volume":"17","author":"Zhang","year":"2021","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.neurol.2025.06.005_bib0250","doi-asserted-by":"crossref","first-page":"105521","DOI":"10.1016\/j.msard.2024.105521","article-title":"Efficacy and comparison of corticosteroids only and corticosteroids with plasmapheresis or intravenous immunoglobulin for the treatment of optic neuritis in demyelinating disease: a systematic review and network meta-analysis","volume":"85","author":"Gaulier","year":"2024","journal-title":"Mult Scler Relat Disord"},{"issue":"7","key":"10.1016\/j.neurol.2025.06.005_bib0255","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1001\/archophthalmol.2012.1126","article-title":"Treatment of optic neuritis by plasma exchange (add-on) in neuromyelitis optica","volume":"130","author":"Merle","year":"2012","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.neurol.2025.06.005_bib0260","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.msard.2018.01.010","article-title":"Beneficial effect of plasma exchange in acute attack of neuromyelitis optica spectrum disorders","volume":"20","author":"Srisupa-Olan","year":"2018","journal-title":"Mult Scler Relat Disord"},{"issue":"4","key":"10.1016\/j.neurol.2025.06.005_bib0265","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/jca.21788","article-title":"Double-blind randomized controlled trial of therapeutic plasma exchanges vs. sham exchanges in moderate-to-severe relapses of multiple sclerosis","volume":"35","author":"Brochet","year":"2020","journal-title":"J Clin Apher"},{"key":"10.1016\/j.neurol.2025.06.005_bib0270","doi-asserted-by":"crossref","first-page":"577604","DOI":"10.1016\/j.jneuroim.2021.577604","article-title":"Rescue immunoadsorption treatment for neuromyelitis optica spectrum disorder attacks unresponsive to intravenous methylprednisolone","volume":"356","author":"Li","year":"2021","journal-title":"J Neuroimmunol"},{"issue":"3","key":"10.1016\/j.neurol.2025.06.005_bib0275","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/jca.21705","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice\u00a0\u2013\u00a0Evidence-based approach from the Writing Committee of the American Society for Apheresis: the Eighth Special Issue","volume":"34","author":"Padmanabhan","year":"2019","journal-title":"J Clin Apher"},{"issue":"2","key":"10.1016\/j.neurol.2025.06.005_bib0285","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1159\/000224630","article-title":"Plasma exchange therapy in steroid-unresponsive relapses in patients with multiple sclerosis","volume":"28","author":"Trebst","year":"2009","journal-title":"Blood Purif"},{"key":"10.1016\/j.neurol.2025.06.005_bib0280","doi-asserted-by":"crossref","first-page":"577604","DOI":"10.1016\/j.jneuroim.2021.577604","article-title":"Rescue immunoadsorption treatment for neuromyelitis optica spectrum disorder attacks unresponsive to intravenous methylprednisolone","volume":"356","author":"Li","year":"2021","journal-title":"J Neuroimmunol"},{"issue":"4","key":"10.1016\/j.neurol.2025.06.005_bib0290","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s10384-018-0602-9","article-title":"Short-term effect of additional apheresis on visual acuity changes in patients with steroid-resistant optic neuritis in neuromyelitis optica spectrum disorders","volume":"62","author":"Mori","year":"2018","journal-title":"Jpn J Ophthalmol"},{"issue":"4","key":"10.1016\/j.neurol.2025.06.005_bib0295","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1136\/jnnp-2017-316286","article-title":"Short delay to initiate plasma exchange is the strongest predictor of outcome in severe attacks of NMO spectrum disorders","volume":"89","author":"Bonnan","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2025.06.005_bib0300","doi-asserted-by":"crossref","first-page":"101506","DOI":"10.1016\/j.msard.2019.101506","article-title":"A pilot study comparing treatments for severe attacks of neuromyelitis optica spectrum disorders: intravenous methylprednisolone (IVMP) with add-on plasma exchange (PLEX) versus simultaneous ivmp and PLEX","volume":"38","author":"Songthammawat","year":"2020","journal-title":"Mult Scler Relat Disord"},{"issue":"3","key":"10.1016\/j.neurol.2025.06.005_bib0305","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.21037\/apm-21-177","article-title":"The efficacy of therapeutic apheresis in patients with refractory neuromyelitis optica spectrum disorders: a single-center retrospective study","volume":"10","author":"Zhang","year":"2021","journal-title":"Ann Palliat Med"},{"issue":"4","key":"10.1016\/j.neurol.2025.06.005_bib0310","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/jca.21686","article-title":"Immunoadsorption or plasma exchange in steroid-refractory multiple sclerosis and neuromyelitis optica","volume":"34","author":"Lipphardt","year":"2019","journal-title":"J Clin Apher"},{"key":"10.1016\/j.neurol.2025.06.005_bib0365","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/WNO.0000000000001684","article-title":"The treatment of myelin oligodendrocyte glycoprotein antibody disease: a state-of-the-art review","volume":"42","author":"Chwalisz","year":"2022","journal-title":"J Neuroophthalmol"},{"key":"10.1016\/j.neurol.2025.06.005_bib0315","doi-asserted-by":"crossref","DOI":"10.1177\/1756286420947977","article-title":"Vision improvement in severe acute isolated optic neuritis after plasma exchange treatment in Chinese population: a prospective case series study","volume":"13","author":"Tan","year":"2020","journal-title":"Ther Adv Neurol Disord"},{"issue":"22","key":"10.1016\/j.neurol.2025.06.005_bib0320","doi-asserted-by":"crossref","first-page":"e2065","DOI":"10.1212\/WNL.0000000000008551","article-title":"Prognostic indicators of improvement with therapeutic plasma exchange in pediatric demyelination","volume":"93","author":"Savransky","year":"2019","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.neurol.2025.06.005_bib0325","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1177\/1352458512471875","article-title":"Factors associated with the effectiveness of plasma exchange for the treatment of NMO-IgG-positive neuromyelitis optica spectrum disorders","volume":"19","author":"Lim","year":"2013","journal-title":"Mult Scler"},{"issue":"10","key":"10.1016\/j.neurol.2025.06.005_bib0330","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3390\/brainsci9100267","article-title":"Therapeutic plasma exchange in multiple sclerosis and autoimmune encephalitis: a comparative study of indication, efficacy and safety","volume":"9","author":"Moser","year":"2019","journal-title":"Brain Sci"},{"issue":"6","key":"10.1016\/j.neurol.2025.06.005_bib0335","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1159\/000504027","article-title":"Visual outcomes of plasma exchange treatment of steroid-refractory optic neuritis: a retrospective monocentric analysis","volume":"46","author":"Skorupka","year":"2019","journal-title":"Transfus Med Hemotherapy"},{"issue":"2","key":"10.1016\/j.neurol.2025.06.005_bib0340","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1600-0404.2011.01612.x","article-title":"Treatment of steroid-unresponsive optic neuritis with plasma exchange","volume":"126","author":"Roesner","year":"2012","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.neurol.2025.06.005_bib0345","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.msard.2018.12.010","article-title":"Outcomes from acute attacks of neuromyelitis optica spectrum disorder correlate with severity of attack, age and delay to treatment","volume":"28","author":"Banerjee","year":"2019","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.neurol.2025.06.005_bib0350","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s40120-022-00344-w","article-title":"Efficacy of plasma exchange treatment for demyelinating optic neuritis associated with various serum antibodies: a prospective cohort study","volume":"11","author":"Fu","year":"2022","journal-title":"Neurol Ther"},{"key":"10.1016\/j.neurol.2025.06.005_bib0355","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/ana.24554","article-title":"Neuromyelitis optica: evaluation of 871 attacks and 1153 treatment courses","volume":"79","author":"Kleiter","year":"2016","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2025.06.005_bib0360","doi-asserted-by":"crossref","first-page":"e504","DOI":"10.1212\/NXI.0000000000000504","article-title":"Apheresis therapies for NMOSD attacks: a retrospective study of 207 therapeutic interventions","volume":"5","author":"Kleiter","year":"2018","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.neurol.2025.06.005_bib0390","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3988\/jcn.2013.9.1.36","article-title":"Clinical efficacy of plasmapheresis in patients with neuromyelitis optica spectrum disorder and effects on circulating anti-aquaporin-4 antibody levels","volume":"9","author":"Kim","year":"2013","journal-title":"J Clin Neurol Seoul Korea"},{"key":"10.1016\/j.neurol.2025.06.005_bib0370","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ejpn.2020.10.005","article-title":"EU paediatric MOG consortium consensus: part 5\u00a0\u2013\u00a0Treatment of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders","volume":"29","author":"Bruijstens","year":"2020","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.neurol.2025.06.005_bib0380","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1001\/archneurol.2011.34","article-title":"Beneficial plasma exchange response in central nervous system inflammatory demyelination","volume":"68","author":"Maga\u00f1a","year":"2011","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neurol.2025.06.005_bib0385","doi-asserted-by":"crossref","first-page":"e0134583","DOI":"10.1371\/journal.pone.0134583","article-title":"Response to therapeutic plasma exchange as a rescue treatment in clinically isolated syndromes and acute worsening of multiple sclerosis: a retrospective analysis of 90 patients","volume":"10","author":"Ehler","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.neurol.2025.06.005_bib0375","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1177\/11206721211028050","article-title":"Optic neuritis classification in 2021","volume":"32","author":"Ducloyer","year":"2021","journal-title":"Eur J Ophthalmol"}],"container-title":["Revue Neurologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378725005454?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378725005454?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T12:58:20Z","timestamp":1755953900000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0035378725005454"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":39,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S0035378725005454"],"URL":"https:\/\/doi.org\/10.1016\/j.neurol.2025.06.005","relation":{},"ISSN":["0035-3787"],"issn-type":[{"type":"print","value":"0035-3787"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Criteria for the use of plasmapheresesis in optic neuritis: A practice review from French expert centers","name":"articletitle","label":"Article Title"},{"value":"Revue Neurologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurol.2025.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}